Search

everythinglearnresearchcommunity

for

Search:↓

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Spironolactone most effective for hirsutism, but has side effects.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Pegvaliase is recommended for treating adults with phenylketonuria.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

The document concludes that minoxidil and finasteride are proven for hair growth, herbal remedies show promise, but more research is needed to confirm their effectiveness.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Iron deficiency common in women, not always linked to hair loss; more research needed.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Doctors need to be better prepared to assess and treat obesity in patients.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.